Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma

Main Article Content

Ahmet Sarici
Soykan Bicim
Mehmet Ali Erkurt
Ilhami Berber
Emin Kaya
Irfan Kuku
Mustafa Ozgul

Abstract

The Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus detected in the Wuhan Province of the People's Republic of China caused a pandemic in a very short time all over the world. Convalescent plasma (CP) therapy is a passive antibody therapy that has been shown to be effective in epidemic periods. CP therapy has been of interest in the treatment of infection with no vaccine or specific treatment, such as the Sars-CoV-2 infection that causes COVID-19. We aimed to report our CP experience in Sars-Cov-2 infection in our relapsed / refractory Multiple myeloma (MM) patient.

Downloads

Download data is not yet available.

Article Details

How to Cite
Sarici, A., Bicim, S., Erkurt, M. A., Berber, I., Kaya, E., Kuku, I., & Ozgul, M. (2021). Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma. Annals of Medical Research, 28(12), 2239–2241. Retrieved from https://annalsmedres.org/index.php/aomr/article/view/4008
Section
Case Reports

Most read articles by the same author(s)

<< < 1 2 3